Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
|
Device | HER2 CISH PHARMDX KIT |
Generic Name | Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer |
Applicant | DAKO DENMARK A/S 42 PRODUKTIONSVEJ DK-2600 GLOSTRUP DK-26-2600 |
PMA Number | P100024 |
Supplement Number | S008 |
Date Received | 01/08/2016 |
Decision Date | 01/29/2016 |
Withdrawal Date
|
01/24/2018 |
Product Code |
NYQ |
Advisory Committee |
Pathology |
Supplement Type | 30-Day Notice |
Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement CHANGE OF THE IN-PROCESS QC "METAPHASE FISH TEST', WITH CHANGE NUMBER R02285. PMA APPROVED DEVICES AFFECTED BY THE CHANGE ARE: HER2 CISH PHARMDX KIT AND HER2 IQFISH PHARMDX. |
|
|